We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Drug Discovery

Drug Discovery

Stay up to date on the topics that matter to you

Trending News

Rice husk, waste from rice processing.

Rice Bran Nanoparticles Show Promise as Anti-Cancer Agent

Two sleeves of oral medication.

Study Investigates How Aspirin Helps To Prevent Colorectal Cancer Development

A network of green vessels with parts highlighted in red.

Fibrin Immunotherapy’s Potential for Treating Traumatic Brain Injury

Hidden Brain Region May Unlock New Epilepsy Treatment

Cell Therapy Treatment Effectively Treats Immune-Compromised Children

Siblings' Rare Genetic Mutation Offers Clues for Type 1 Diabetes Therapy

News

Halozyme Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target

Halozyme grants exclusive, global rights to Roche for use of Enhanze™ Technology with biologics directed against fourth target.

New Targeted Fluorescent-Imaging Compound Allows Researchers to Detect Viable Cancer Cells in Mice

Researchers develop a new type of imaging compound to visualize viable breast cancer cells that have spread to the lungs in mice.

Seattle Genetics Reports Durable Objective Responses with SGN-35 in Lymphoma

Reported demonstrate enhanced activity of dacetuzumab combined with Rituxan in patients with relapsed or refractory Hodgkin lymphoma.

Study Sheds Light on Causes of HIV Dementia

Einstein researchers clarify how two major variants of HIV differ in their ability to cause neurologic complications.

Evotec Announces Three-Year Drug Discovery Collaboration

Evotec to use its drug discovery platform and expertise to advance a drug discovery program against a target nominated by Novartis.

Roche Applied Science Introduces new xCELLigence RTCA MP Instrument

The xCELLigence RTCA MP allows high throughput online-measurement of cell activities without labeling.

Millipore Corporation Signs License Agreement with Astellas

Millipore's UCOE™ technology chosen by Astellas to produce its drug targets by generating higher protein yields.

Osiris Completes Enrollment in First Worldwide Phase III Stem Cell Trial

The trial will assess safety and efficacy of Prochymal for the treatment of steroid-refractory acute Graft versus Host Disease.

PerkinElmer Announces Strategic Acquisition of Arnel

The acquisition expands PerkinElmer’s chromatography portfolio and strengthen its commitment to hydrocarbon processing industries.

PRA International Announces Collaboration with Frontage Laboratories

The partnership will enable PRA Early Development Services’ US Clinical Pharmacology Center to offer analytical lab testing services in North America.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter